Why Personalization Matters in GLP-1 Treatment Individual responses to GLP-1 therapy vary significantly based on genetics, metabolism, and lifestyle factors
The drug works by mimicking a hormone that targets areas of the brain regulating appetite, thus reducing hunger
It does this by stimulating neurons in the central nervous system in a way that releases two neurotransmitters related to appetite: dopamine and norepinephrine
CyberKnife robotic surgery: This state-of-the-art treatment delivers precise, high-dose radiation to tumors, while also protecting healthy tissues in the body
Large epidemiological studies linked their use to lower dementia risk, preclinical models showed neuroprotective and anti-inflammatory effects, and the receptor was known to be present in the brain
The NrF2/ARE pathway is an important signaling pathway that reduces skin damage caused by UVB radiation (137)